Oxytocin S 25ml

Target Species Cattle, horses, pigs, sheep, goats, cats and dogs Indications for use Injections with this product will initiate strong, regular and purposeful contractions of the uterine muscle especially in the later stages of pregnancy and post-partum. It also evokes the 'let-down' of milk although it has no action on the smooth muscles of the gut or urinary bladder, nor is it effective in the treatment of diabetes insipidus. The absence of vasopressor and antidiuretic effects make it particularly suitable for obstetric use (stimulation of parturition, promotion of uterine involution and control of post-partum haemorrhage) and the treatment of agalactia. The product is indicated for: - stimulation of uterine contraction to facilitate parturition in the presence of a fully dilated cervix - to promote involution of the post-parturient uterus and thus aid the passage of retained placenta - to aid in control of post-partum haemorrhage - promotion of milk 'let-down' in cases of agalactia and to facilitate ‘stripping out’ of infected quarters in the treatment of mastitis in cows. Contraindications 1. When the product is used as an aid to parturition, cervical dilation must be confirmed prior to administration to prevent the risk of foetal death and possible uterine rupture. 2. The product is contraindicated in any form of obstructive dystocia. 3. Excessive doses of the product may delay parturition by producing incoordinated uterine contractions which interfere with the progress of the foetus especially in multiple pregnancies. 4. The effects of daily dosages of 100 iu or more (to facilitate ‘stripping out’ of infected quarters in the treatment of mastitis in cows) on the oestrous cycle have not been fully investigated and the cycle length may be altered. 5. Adrenaline at physiological levels markedly reduces the effect of oxytocin on the uterus or mammary gland. For this reason, the animal should not be frightened when complete oxytocin effect is desired to cause either milk 'letdown' or uterine contractions. Special warnings for each target species None Special precautions for use Use aseptic precautions. Operator warnings Pregnant or lactating women should avoid handling the product as it could cause smooth muscle (e.g. uterine) contraction. When administering the product, care should be taken to avoid accidental self-injection. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Adverse Reactions None known Use during pregnancy or lactation Used to promote parturition and milk let-down. Not to be used in late pregnancy unless the intention is to promote parturition. Interactions Stimulation of beta-adrenergic receptors may reduce the effect of oxytocin on the uterus or mammary gland.
Vat Rate: 20%